Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	53.12	53.51	-21.15	-44.88	-42.04	-57.2
Depreciation & Amortization	10.79	6.55	2.85	1.86	1.22	0.84
Loss (Gain) From Sale of Investments	-2.02	-8.86	-2.47	-0	0.01	-
Stock-Based Compensation	130.14	116.01	82.47	51.97	26.48	13.11
Provision & Write-off of Bad Debts	0.72	-0.77	1.61	-0.06	-	-
Other Operating Activities	1.89	1.52	2.13	0.88	1.07	1.09
Change in Accounts Receivable	-58.17	-2.6	-30.22	-27.02	-9.24	-11.84
Change in Inventory	-62.61	-46.23	-22	5.35	-8.75	-2.65
Change in Accounts Payable	17.42	0.6	9.3	14.36	4.78	2.05
Change in Other Net Operating Assets	26.17	10.52	2.14	9.13	6.36	1.56
Operating Cash Flow	117.45	130.25	24.65	11.57	-20.12	-53.05
Operating Cash Flow Growth	295.61%	428.32%	113.09%	-	-	-
Capital Expenditures	-32.44	-39.12	-23.63	-9.1	-4.67	-2.46
Investment in Securities	-21.76	-74	-271.19	-10.5	33.81	89.08
Investing Cash Flow	-54.2	-113.12	-294.82	-19.6	29.14	86.63
Long-Term Debt Repaid	-	-	-	-24.5	-	-
Net Debt Issued (Repaid)	-	-	-	-24.5	-	-
Issuance of Common Stock	27.08	27.77	31.11	259.62	14.95	134.07
Repurchase of Common Stock	-171.39	-80.17	-17.16	-0.04	-	-
Financing Cash Flow	-144.31	-52.39	13.95	235.08	14.95	134.07
Foreign Exchange Rate Adjustments	-0.04	-0.12	0.16	0.08	-0.02	0.01
Net Cash Flow	-81.11	-35.39	-256.06	227.13	23.95	167.66
Free Cash Flow	85.01	91.12	1.02	2.47	-24.79	-55.5
Free Cash Flow Growth	-	8798.73%	-58.59%	-	-	-
Free Cash Flow Margin	9.87%	11.35%	0.16%	0.61%	-10.62%	-48.10%
Free Cash Flow Per Share	2.79	2.98	0.04	0.09	-0.91	-2.13
Cash Interest Paid	0.03	0.02	-	2.32	1.89	1.89
Levered Free Cash Flow	55.1	62.72	0.03	17.43	-10.69	-34.6
Unlevered Free Cash Flow	55.12	62.73	0.03	18.48	-9.36	-33.27
Change in Working Capital	-77.18	-37.71	-40.78	1.81	-6.86	-10.88

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q